| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMC070201 |
| P698 | PubMed publication ID | 17596618 |
| P50 | author | Olof Eriksson | Q66145253 |
| P2093 | author name string | Torbjörn Lundgren | |
| Nordic Network for Clinical Islet Transplantation | |||
| Torsten Eich | |||
| P4510 | describes a project that uses | positron emission tomography | Q208376 |
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | visualization | Q451553 |
| P304 | page(s) | 2754-2755 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. | |
| P478 | volume | 356 |
| Q93192279 | A novel model for in vivo quantification of immediate liver perfusion impairment after pancreatic islet transplantation |
| Q37217407 | Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation |
| Q92424036 | Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics |
| Q88244023 | An engineered cell sheet composed of human islets and human fibroblast, bone marrow-derived mesenchymal stem cells, or adipose-derived mesenchymal stem cells: An in vitro comparison study |
| Q31047685 | Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture |
| Q37193323 | Autologous pancreatic islet transplantation in human bone marrow. |
| Q58763032 | Biomarkers in Islet Cell Transplantation for Type 1 Diabetes |
| Q33636425 | Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? |
| Q92068931 | Change in Viability and Function of Pancreatic Islets after Coculture with Mesenchymal Stromal Cells: A Systemic Review and Meta-Analysis |
| Q26851906 | Clinical imaging in regenerative medicine |
| Q51027258 | Co-transplantation of Xenogeneic Bone Marrow-derived Mesenchymal Stem Cells Alleviates Rejection of Pancreatic Islets in Non-obese Diabetic Mice. |
| Q48014172 | Comparison of the Ovary and Kidney as Sites for Islet Transplantation in Diabetic Rats |
| Q87039180 | Current status of clinical islet transplantation |
| Q45798448 | Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging |
| Q39989398 | Distinct activation of primary human BDCA1(+) dendritic cells upon interaction with stressed or infected β cells |
| Q82591331 | Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats |
| Q37072675 | Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients |
| Q43707258 | Endothelial microparticles released by activated protein C protect beta cells through EPCR/PAR1 and annexin A1/FPR2 pathways in islets |
| Q96951726 | Engineering immunomodulatory biomaterials for type 1 diabetes |
| Q53382655 | Extensive Loss of Islet Mass Beyond the First Day After Intraportal Human Islet Transplantation in a Mouse Model. |
| Q42552463 | FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model |
| Q92273631 | Fewer Islets Survive from a First Transplant than a Second Transplant: Evaluation of Repeated Intraportal Islet Transplantation in Mice |
| Q38755069 | First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2b: genetically modified source pigs |
| Q38523287 | Growing applications of FDG PET-CT imaging in non-oncologic conditions |
| Q41689680 | Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis |
| Q36770646 | Identification of tissue-specific cell death using methylation patterns of circulating DNA |
| Q57168325 | Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa |
| Q36839324 | Imaging the Beta-cell mass: why and how |
| Q37935646 | Imaging the islet graft by positron emission tomography |
| Q37853194 | Immune and cell therapy in type 1 diabetes: too little too late? |
| Q37809052 | Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events |
| Q37729050 | Immunological aspects of pancreatic islet cell transplantation |
| Q59129861 | Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells |
| Q42170347 | In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates |
| Q38689971 | Islet cell transplant: Update on current clinical trials |
| Q27010290 | Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges |
| Q53457111 | Islet heparan sulfate but not heparan sulfate proteoglycan core protein is lost during islet isolation and undergoes recovery post-islet transplantation. |
| Q45842524 | Islet survival and function following intramuscular autotransplantation in the minipig |
| Q37088225 | Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome |
| Q44522147 | Liver perfusion changes occurring during pancreatic islet engraftment: a dynamic contrast-enhanced magnetic resonance study. |
| Q38797868 | Long-term function and optimization of mouse and human islet transplantation in the subcutaneous device-less site |
| Q36030491 | Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation |
| Q37527795 | MRI as a tool to monitor islet transplantation |
| Q52575818 | Magnetic particle imaging of islet transplantation in the liver and under the kidney capsule in mouse models. |
| Q54519533 | Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecules. |
| Q37947597 | Molecular imaging: a promising tool to monitor islet transplantation |
| Q83719519 | Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification |
| Q30354756 | New Bioengineering Breakthroughs and Enabling Tools in Regenerative Medicine |
| Q37096895 | Non-invasive detection of transplanted pancreatic islets |
| Q53439562 | Novel culture technique involving an histone deacetylase inhibitor reduces the marginal islet mass to correct streptozotocin-induced diabetes. |
| Q35668519 | Pancreatic Islet Survival and Engraftment Is Promoted by Culture on Functionalized Spider Silk Matrices |
| Q41767345 | Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients. |
| Q52883145 | Positron Emission Tomography and Autoradiography of (18)F-Fluorodeoxyglucose Labeled Islets With or Without Warm Ischemic Stress in Portal Transplanted Rats. |
| Q40955221 | Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation |
| Q37269443 | Primary graft function, metabolic control, and graft survival after islet transplantation |
| Q37268202 | Reparixin, a CXCR1/2 inhibitor in islet allotransplantation |
| Q39015256 | Shielding Engineered Islets With Mesenchymal Stem Cells Enhance Survival Under Hypoxia |
| Q37914760 | State of the art of clinical islet transplantation and novel protocols of immunosuppression |
| Q88957417 | Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges |
| Q38840396 | Surgical approaches to chronic pancreatitis: indications and imaging findings |
| Q89531583 | Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes |
| Q37379860 | The choice of anatomical site for islet transplantation |
| Q38588520 | The immunological barriers to xenotransplantation |
| Q38526686 | Total pancreatectomy and islet autotransplantation for chronic pancreatitis: spectrum of postoperative CT findings |
| Q90611838 | Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model |
| Q30419163 | Update on islet cell transplantation for type 1 diabetes |
| Q36065843 | Update on islet transplantation |
| Q42943630 | Vascularization of artificial beds for pancreatic islet transplantation in a rat model |
Search more.